Free Webex Call
The global Equine Pharmaceuticals & Supplements market was valued at USD 972.89 million in 2024 and is expected to experience substantial growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market includes a wide range of products and services aimed at promoting the health and well-being of horses. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
It encompasses pharmaceuticals, nutritional supplements, and healthcare services specifically designed for equines, with the goal of maintaining their health, improving performance, and addressing various medical conditions. For example, in March 2024, the American Association of Equine Practitioners (AAEP) released updated vaccination protocols for five critical equine diseases prevalent in the U.S. These diseases - West Nile virus, tetanus, equine encephalomyelitis, and rabies - have protocols designed to improve prevention efforts and ensure the health and safety of horses nationwide.
Key Market Drivers:
Increasing Equine Population
The global equine industry has seen a notable and steady rise in the equine population, which has significantly influenced the growth of the Equine Pharmaceuticals & Supplements market. There has been a marked increase in participation in equestrian activities such as horse riding, show jumping, and dressage, leading to a higher demand for horses for both sporting and recreational purposes. Beyond sports and leisure, horses are vital in industries such as agriculture, tourism, therapy, and law enforcement. As these sectors grow, the need for a larger equine workforce has also increased. Additionally, horses have become increasingly popular as companion animals, contributing to a surge in ownership.Key Market Challenges:
Counterfeit Products
The presence of counterfeit equine pharmaceuticals and supplements remains a significant challenge. These products are often of subpar quality, containing incorrect ingredients or dosages, which could endanger the health of horses and undermine consumer confidence in the market.Key Market Trends:
Natural and Herbal Supplements
A growing trend within the equine supplements market is the rising demand for natural and herbal alternatives. Horse owners are increasingly seeking holistic solutions to equine health, opting for supplements made from herbs, botanicals, and plant-based ingredients known for their therapeutic benefits. These products are perceived as gentler alternatives to conventional pharmaceuticals.Key Market Players:
- Zoetis Inc
- Boehringer Ingelheim GmbH
- Merck & Co Inc
- Elanco Animal Health Inc
- Bayer AG
- Ceva Santé Animale SA
- Virbac SA
- Vetoquinol SA
- Affymetrix Inc
- Celltrion Inc
Report Scope:
This report segments the global Equine Pharmaceuticals & Supplements market into the following categories, and provides insights into the industry trends:
By Product:
- Pharmaceuticals
- Supplements
By Distribution Channel:
- Drug Stores
- Veterinary Hospitals
- Other Channels
By Region:
North America:
United States, Canada, MexicoEurope:
Germany, United Kingdom, France, Italy, SpainAsia-Pacific:
China, Japan, India, Australia, South KoreaSouth America:
Brazil, Argentina, ColombiaMiddle East & Africa:
South Africa, Saudi Arabia, UAE, KuwaitCompetitive Landscape and Company Profiles:
This section provides a detailed analysis of the key players in the global Equine Pharmaceuticals & Supplements market.Available Customizations:
TechSci Research offers customized reports based on specific market data for the Global Equine Pharmaceuticals & Supplements market, catering to individual business needs. Customization options include the profiling and analysis of additional market players (up to five).This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Equine Pharmaceuticals & Supplements Market Outlook
6. North America Equine Pharmaceuticals & Supplements Market Outlook
7. Europe Equine Pharmaceuticals & Supplements Market Outlook
8. Asia-Pacific Equine Pharmaceuticals & Supplements Market Outlook
9. South America Equine Pharmaceuticals & Supplements Market Outlook
10. Middle East and Africa Equine Pharmaceuticals & Supplements Market Outlook
11. Market Dynamics
12. Market Trends & Developments
13. Porter’s Five Forces Analysis
14. Competitive Landscape
Companies Mentioned
- Zoetis Inc
- Boehringer Ingelheim GmbH
- Merck & Co Inc
- Elanco Animal Health Inc
- Bayer AG
- Ceva Sante Animale SA
- Virbac SA
- Vetoquinol SA
- Affymetrix Inc
- Celltrion Inc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 180 |
Published | March 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 972.89 Million |
Forecasted Market Value ( USD | $ 1360 Million |
Compound Annual Growth Rate | 5.9% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |